A detailed history of Brookstone Capital Management transactions in Zoetis Inc. stock. As of the latest transaction made, Brookstone Capital Management holds 3,838 shares of ZTS stock, worth $695,906. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,838
Previous 3,785 1.4%
Holding current value
$695,906
Previous $656,000 14.18%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$172.58 - $196.48 $9,146 - $10,413
53 Added 1.4%
3,838 $749,000
Q2 2024

Jul 18, 2024

SELL
$145.54 - $178.83 $53,995 - $66,345
-371 Reduced 8.93%
3,785 $656,000
Q1 2024

Apr 15, 2024

SELL
$165.67 - $199.94 $103,543 - $124,962
-625 Reduced 13.07%
4,156 $703,000
Q4 2023

Jan 11, 2024

SELL
$151.44 - $200.09 $1.25 Million - $1.65 Million
-8,249 Reduced 63.31%
4,781 $943,000
Q3 2023

Oct 20, 2023

BUY
$167.14 - $192.77 $1.29 Million - $1.48 Million
7,692 Added 144.1%
13,030 $2.27 Million
Q2 2023

Jul 11, 2023

SELL
$160.94 - $186.23 $31,866 - $36,873
-198 Reduced 3.58%
5,338 $919,000
Q1 2023

Apr 18, 2023

SELL
$145.48 - $175.02 $25,168 - $30,278
-173 Reduced 3.03%
5,536 $921,000
Q4 2022

Jan 09, 2023

SELL
$131.14 - $157.47 $7,081 - $8,503
-54 Reduced 0.94%
5,709 $0
Q3 2022

Oct 13, 2022

SELL
$148.29 - $182.55 $89,418 - $110,077
-603 Reduced 9.47%
5,763 $841,000
Q2 2022

Jul 11, 2022

SELL
$155.97 - $200.09 $30,414 - $39,017
-195 Reduced 2.97%
6,366 $1.13 Million
Q1 2022

Apr 12, 2022

SELL
$181.39 - $234.03 $167,060 - $215,541
-921 Reduced 12.31%
6,561 $1.26 Million
Q4 2021

Jan 11, 2022

BUY
$193.69 - $247.03 $221,775 - $282,849
1,145 Added 18.07%
7,482 $1.58 Million
Q3 2021

Nov 03, 2021

BUY
$189.29 - $209.69 $660,243 - $731,398
3,488 Added 122.43%
6,337 $1.25 Million
Q2 2021

Jul 14, 2021

BUY
$155.9 - $187.99 $444,159 - $535,583
2,849 New
2,849 $568,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $84.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Brookstone Capital Management Portfolio

Follow Brookstone Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookstone Capital Management with notifications on news.